Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $82.40 USD
Change Today +1.30 / 1.60%
Volume 1.1M
DVA On Other Exchanges
New York
As of 8:04 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

davita healthcare partners i (DVA) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/27/15 - $85.17
52 Week Low
05/5/14 - $66.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

davita healthcare partners i (DVA) Related Businessweek News

View More BusinessWeek News

davita healthcare partners i (DVA) Details

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2014, the company provided dialysis and administrative services in the United States through a network of 2,179 outpatient dialysis centers in 46 states and the District of Columbia serving approximately 173,000 patients; operated or provided administrative services to a total of 91 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 7,200 patients; and integrated care management services for approximately 837,300 members under its care in southern California, central and south Florida, southern Nevada, central New Mexico, and central Arizona. It also provides acute inpatient dialysis services in approximately 1,000 hospitals and related laboratory services in the United States. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.

57,900 Employees
Last Reported Date: 02/26/15
Founded in 1994

davita healthcare partners i (DVA) Top Compensated Officers

Co-Chairman, Chief Executive Officer and Chie...
Total Annual Compensation: $1.2M
Interim Chief Financial Officer and Chief Acc...
Total Annual Compensation: $650.0K
Chief Executive Officer of International and ...
Total Annual Compensation: $1.0M
Chief Executive Officer of Kidney Care Divisi...
Total Annual Compensation: $800.0K
Chief Legal Officer
Total Annual Compensation: $650.0K
Compensation as of Fiscal Year 2014.

davita healthcare partners i (DVA) Key Developments

DaVita HealthCare Partners Inc. Announces Closing of its Cash Tender Offer for the 2020 Notes and Calls for Redemption of Untendered 2020 Notes

DaVita HealthCare Partners Inc. announced the closing of its previously announced tender offer to purchase for cash (the Tender Offer) any and all of its outstanding 6 5/8% Senior Notes due 2020 (the 2020 Notes). The Tender Offer expired at 5:00 p.m., Eastern Time, on April 20, 2015 (the Expiration Time). At the Expiration Time, valid tenders had been received with respect to approximately $599.6 million of the $775 million aggregate principal amount of the 2020 Notes outstanding. The Company has accepted for payment all 2020 Notes validly tendered prior to the Expiration Time pursuant to the Tender Offer. On April 21, 2015, such tendering holders will receive the purchase price in the amount of $1,053.19 for each $1,000 principal amount of 2020 Notes tendered, plus accrued and unpaid interest to, but not including, the date hereof. In addition, the Company will accept any additional 2020 Notes properly tendered by means of the guaranteed delivery procedures provided. In accordance with the indenture, on April 20, 2015, the Company issued an irrevocable notice of redemption with respect to all outstanding 2020 Notes that were not tendered in the Tender Offer. The redemption date is May 20, 2015.

DaVita HealthCare Partners Inc. Announces Offering of $1.25 Billion Senior Notes

DaVita HealthCare Partners Inc. announced that it intends to offer, subject to market and other conditions, $1.25 billion principal amount of senior notes due 2025. The Company intends to use the net proceeds from the offering to repurchase or redeem its outstanding 6 5/8% Senior Notes due 2020, to pay related transaction fees and expenses, and for general corporate purposes, which may include future acquisitions and share repurchases. Concurrently with this offering, the company has commenced a cash tender offer to purchase the Outstanding Notes. The offering is not conditioned upon the consummation of the tender offer for the Outstanding Notes. The Senior Notes will be guaranteed by certain of the Company's domestic subsidiaries. The Senior Notes are being offered pursuant to an effective registration statement filed with the Securities and Exchange Commission. BofA Merrill Lynch, Barclays, Credit Suisse, Goldman, Sachs & Co., J.P. Morgan, Morgan Stanley, SunTrust Robinson Humphrey and Wells Fargo Securities are acting as joint book-running managers for the offering. Credit Agricole CIB, MUFG, Scotiabank and SMBC Nikko are acting as co-managers for the offering.

DaVita HealthCare Partners Inc. Commences Cash Tender Offer for Any and All of its 6 5/8% Senior Notes Due 2020

DaVita HealthCare Partners Inc. announced that it has commenced a tender offer to purchase for cash any and all of its outstanding 6 5/8% Senior Notes due 2020. The Tender Offer is being made pursuant to an Offer to Purchase and the related Letter of Transmittal, each dated April 14, 2015. The Tender Offer will expire at 5:00 p.m., New York City time, on April 20, 2015, unless extended or earlier terminated as described in the Offer to Purchase.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVA:US $82.40 USD +1.30

DVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apollo Medical Holdings Inc $9.00 USD +4.00
Fresenius Medical Care AG & Co KGaA €76.32 EUR +1.54
Fresenius SE & Co KGaA €54.27 EUR +1.11
IPC Healthcare Inc $48.05 USD -0.87
Team Health Holdings Inc $59.05 USD -0.52
View Industry Companies

Industry Analysis


Industry Average

Valuation DVA Industry Range
Price/Earnings 24.7x
Price/Sales 1.4x
Price/Book 3.4x
Price/Cash Flow 13.5x
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAVITA HEALTHCARE PARTNERS I, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at